| Name | WNY1613 |
|---|
| Description | WNY1613 is a potent and selective PI3Kδ inhibitor with piperazinone-containing purine scaffold. WNY1613 induces cancer cell apoptosis and inhibits the phosphorylation of PI3K downstream components in NHL cell lines. WNY1613 exhibits anti-NHL activity in vitro and in vivo[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C29H35N9O3 |
|---|---|
| Molecular Weight | 557.65 |